Ultragenyx Pharmaceutical – Startup Investor Profile

Ultragenyx Pharmaceutical focuses on the development of various products for the treatment of rare and ultra-rare diseases.

Location: Novato

Country:

Investment Regions:

Investment Stages: late-stage, pre-seed, seed, series-a

Website: http://www.ultragenyx.com/

AI Reasoning: Searches of Ultragenyx Pharmaceutical’s investor relations, press releases, and SEC filings (2022-2025) show no evidence that Ultragenyx has made external venture investments in startups in the past 12 months. The company’s visible activity is corporate operations, financial results, and partnerships/licensing typical for a biopharma developer. The last identifiable external investment or equity participation found in public sources predates the 12-month window; for example, no press release or SEC filing from the past year documents an investment in a startup such as [no recent startup investment found]. Given lack of any public record of an investment within the last 12 months, classify as not-active.

Not Active – No known investments in the last 12 months.

Low Activity – Only known investments between the last 12 and 6 months.

Active – Known investments between the last 6 and 3 months.

Very Active – Known investments in the last 3 months.